Company Executives

$KRYS Management Team

Ms. Meg Dodge

Investor Relations

Age -

Compensation -

Sex Female

Ms. Suma Krishnan

President - Research and Development

Founder

Director

Age 60

Compensation $8.244M USD

Sex Female

Ms. Kathryn Romano

Chief Accounting Officer

Age 44

Compensation $3.054M USD

Sex Female

Mr. Krish Krishnan

Chairman of the Board

President

Chief Executive Officer

Age 60

Compensation $15.60M USD

Sex Male

Name / Title	Age	Compensation	Sex
Ms. Meg Dodge Investor Relations	-	-	Female
Ms. Suma Krishnan President - Research and Development Founder Director	60	$8.244M USD	Female
Ms. Kathryn Romano Chief Accounting Officer	44	$3.054M USD	Female
Mr. Krish Krishnan Chairman of the Board President Chief Executive Officer	60	$15.60M USD	Male

Board of Directors

From the proxy statement filed Apr 3, 2026

Directors

serving now

Independent

6 of 6

stated in the proxy; 2 not stated

Average tenure

6.9 years

from year joined

CEO also chairs the board

Yes

Krish S. Krishnan

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Krish S. Krishnan Board chair, CEO	61	2016 10 years	Not stated	Commercial Advisory Committee · Chair	None stated	Paid as CEO
Christopher Mason	68	2021 5 years	Independent	Science and Technology Committee · Chair	None stated	$468,972
Suma M. Krishnan Executive officer	61	Not stated	Not stated	None stated	None stated	Not stated
Julian S. Gangolli	68	2019 7 years	Independent	Nominating and Corporate Governance Committee · Chair Compensation Committee Audit Committee	Outlook Therapeutics, Inc.	$491,472
Catherine Mazzacco	61	2023 3 years	Independent	Nominating and Corporate Governance Committee Commercial Advisory Committee	Sight Sciences, Inc.	$470,972
Daniel S. Janney Lead independent director	60	2016 10 years	Independent	Compensation Committee · Chair	None stated	$526,472
Dino A. Rossi	71	2017 9 years	Independent	Audit Committee · Chair Compensation Committee	None stated	$491,972
E. Rand Sutherland	56	2022 4 years	Independent	Audit Committee Commercial Advisory Committee	Upstream Bio, Inc.	$476,472

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 3, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$KRYS Management Team

Ms. Meg Dodge

Ms. Suma Krishnan

Ms. Kathryn Romano

Mr. Krish Krishnan

Board of Directors

Related-party transactions

No related-party transactions disclosed